In addition, we also confirmed that the promoting effect of PSMC2/RPS15A on gastric cancer progression, suggesting that PSMC2/RPS15A may be potential targets for targeted therapy of gastric cancer. This evidence concerns the gene PSMC2 and gastric cancer.